|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Current assets: | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Due from Sponsor | ||||||
| Related Party | ||||||
| Total due from Sponsor | ||||||
| Total Current Assets | ||||||
| Deferred offering costs | ||||||
| Long-term prepaid insurance | ||||||
| Marketable securities held in Trust Account | ||||||
| Cash and marketable securities held in Trust Account | ||||||
| Total Assets | ||||||
| Current liabilities: | ||||||
| Accrued expenses | ||||||
| Accrued offering costs | ||||||
| IPO Promissory Note – related party | ||||||
| Total Current Liabilities | ||||||
| Deferred Underwriting Fee payable | ||||||
| Deferred Fee payable | ||||||
| Total Liabilities | ||||||
| Class A Ordinary Shares subject to possible redemption, $0.0001 par value; 23,000,000 and 23,000,000 shares issued and outstanding at redemption value of $10.49 and $10.30 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||
| Shareholders’ Deficit | ||||||
| Ordinary shares, value | ||||||
| Class A Ordinary Shares | ||||||
| Class B Ordinary Shares | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit |
Loading...
